Epilepsy Trial, Recruiting NCT05527093 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT05527093
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who can read and speak French well
  • People who have given written agreement to take part in the trial
  • People who have had focal temporal lobe epilepsy (a type of epilepsy affecting one area of the brain) for at least one year, which has not been controlled by medications, and is caused by scarring in a part of the brain called the hippocampus
  • People who are currently going through a pre-surgical assessment (tests to see if brain surgery may be an option)
  • People who are part of the French social security system

Who may not be able to join:

  • People who are under legal protection or guardianship
  • People who have claustrophobia (fear of enclosed spaces) or any other reason they cannot safely have an MRI scan
  • People who are pregnant or breastfeeding
  • People who are currently taking part in another research study that has a required waiting period before joining a new study
  • People who do not agree to be informed if something unexpected is found during their MRI scan

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 1 42 16 03 01

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 March 2025
Est. completion
19 January 2029

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Measure of fractional anisotropy (scalar parameters, between 0 and 1) of long and short white-matter tracts involved in social cognition, in healthy subjects and patients with epilepsy; measure of mean diffusivity (in mm2/s) of long and short white matter tracts involved in social cognition, in healthy subjects and patients with epilepsy; number of fibers in each long and white matter tracts involved in social cognition; angular dispersion (degree/m) of axons in long and short white matter tracts involved in social cognition, in healthy subjects and patients with epilepsy; measure of functiona...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov